Attendees will have the opportunity to hear the results of cutting edge studies, and to learn about the new Guidelines which are likely to have a tremendous impact on the European health care system.
[More]
Kavitha Chinnaiyan, M.D., director of Advanced Cardiac Imaging Education at Beaumont Hospital, Royal Oak, has received the Frank J. McDevitt, D.O., Award for Excellence in Health Policy Research for Physicians.
[More]
Researchers at the Intermountain Heart Institute at Intermountain Medical Center have developed a new 3-D technology that for the first time allows cardiologists the ability to see the precise source of atrial fibrillation in the heart - a breakthrough for a condition that affects nearly three million Americans.
[More]
Colorado Governor John W. Hickenlooper has proclaimed May to be Cardiac Arrhythmia Awareness Month (#RhythmAwareness), calling attention to the need for greater public awareness throughout the State about two serious heart rhythm disorders, atrial fibrillation (also known as AF or AFib) and sudden cardiac arrest (also known as SCA).
[More]
BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator series.
[More]
The strength of interaction between atopy and elevated eosinophil levels in asthma decreases with age, a study finds.
[More]
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than those of people without schizophrenia.
[More]
The U.S. Food and Drug Administration today approved Kcentra (Prothrombin Complex Concentrate, Human) for the urgent reversal of vitamin K antagonist anticoagulation in adults with acute major bleeding.
[More]
Children with asthma who are overweight are more likely to experience symptoms after exposure to indoor air pollution than normal-weight asthmatic children, show study findings.
[More]
Unrecognized atrial fibrillation could be a cause of some wake-up strokes, say researchers who found an increased prevalence of the arrhythmia in patients who had stroke symptoms on waking.
[More]
The Heart Failure Congress 2013 promises more science than ever this year, with a record number of abstracts submitted. The congress takes place 25-28 May at the Centro de Congressos de Lisboa in Lisbon, Portugal.
[More]
A practical guide on the use of the new oral anticoagulants has been produced by the European Heart Rhythm Association of the European Society of Cardiology.
[More]
UK researchers have found that despite being a major contributor to premature deaths among patients with schizophrenia, cardiovascular disease is less likely to be recorded on their primary care records than people without schizophrenia.
[More]
Perosphere Inc. and Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that they have entered into a clinical trial agreement under which Daiichi Sankyo will support and co-sponsor a phase 1 clinical study testing the safety, tolerability and effectiveness of PER977 to reverse the anticoagulant activity of edoxaban, Daiichi Sankyo's investigational oral, once-daily, direct factor Xa-inhibitor.
[More]
ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has entered into an agreement with Medtronic, Inc., a leader in medical technologies to improve the treatment of chronic diseases, including cardiac rhythm disorders, to collaborate on ARCA's proposed clinical trial, known as GENETIC-AF, of its lead developmental drug Gencaro (bucindolol hydrochloride).
[More]
A common test that records the heart's electrical activity could predict potentially serious cardiovascular illness, according to a UC San Francisco-led study.
[More]
A study published today in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation, the opposite of results just published by another group in the same journal analyzing the same data.
[More]
Doctors at UCSF Medical Center implanted a new cardiac defibrillator that uses a single-lead to sense vital changes in the heart rhythm on March 14, 2013, becoming one of the first heart centers in Northern California to perform this procedure.
[More]
Computational models of the human heart can be very useful in studying not just the basic mechanisms of heart function, but also to analyze the heart in a diseased state, and come up with methods for diagnosis and therapy.
[More]
UCLA researchers have used a brain-imaging tool and stroke risk assessment to identify signs of cognitive decline early on in individuals who don't yet show symptoms of dementia.
[More]